Advances and Challenges in Nanomedicine: Translating Nanotechnology into Therapeutics for Cancer, Neurodegenerative, and Infectious Diseases
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 2587
Special Issue Editors
Interests: nanomedicine; 3D culture; bioplotting; organ on chip; stem cells; tissue regeneration; regenerative medicine; cancer; histology and molecular biology analyses
Special Issues, Collections and Topics in MDPI journals
Interests: drug delivery systems; nanomedicine; tissue engineering; microfluidics technology; lipid nanoparticles; liposomes; polyesters-based carriers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The field of nanomedicine holds immense promise for transforming therapeutic and diagnostic approaches, enabling targeted drug delivery, enhanced imaging, and personalized medicine solutions. Recent advances have led to a surge in the development of lipid nanoparticles, polymer-based carriers, and inorganic nanomaterials that are not only designed to improve drug stability and bioavailability but also to overcome traditional challenges associated with drug delivery, such as toxicity and biodistribution. This Special Issue seeks to showcase cutting-edge research and comprehensive reviews on the design, characterization, and clinical translation of nanomaterials in medicine. We invite manuscripts focusing on innovative formulations, nanoparticle-based gene therapies, immunotherapies, and theranostics, as well as on the regulatory and manufacturing challenges facing the field. We welcome submissions exploring nanomedicine's impact in emerging areas such as cancer, neurodegenerative diseases, and infectious diseases.
Topics of interest include, but are not limited to, the following:
- Design and optimization of lipid nanoparticles, polymeric nanoparticles, and hybrid nanocarriers for targeted delivery;
- Nanoformulations for gene therapy, including mRNA and siRNA delivery;
- Advances in nanoparticle-mediated immunotherapy;
- Overcoming physiological barriers with nano-based delivery systems;
- Theranostic nanoparticles for simultaneous diagnosis and therapy;
- Safety, toxicity, and immunogenicity of nanomedicines;
- Regulatory and manufacturing perspectives on nanomedicine development;
- Case studies of nanomedicine applications in cancer, infectious diseases, and neurological disorders.
We aim to bring together pioneering researchers and industry professionals to address the current advancements and challenges in translating nanotechnology into viable clinical solutions. This Special Issue will serve as a valuable resource for scientists and practitioners committed to advancing the frontier of nanomedicine.
Prof. Dr. Giovanna Della Porta
Dr. Erwin Pavel Lamparelli
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomedicine
- targeted delivery
- gene therapies
- immunotherapies
- cancer
- infectious diseases
- neurological disorders
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
